ARCHIVES

RFOs Available, Contract Awards, Sole Source Negotiations

This article is from The Cancer Letter archive.

Vol. 04 No. 05 | February 3, 1978

Download PDF Visit The Full Archive

Related Articles

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years

July 4, 1997